European Parliament to vote on patient information proposal
This article was originally published in Scrip
Executive Summary
The European Parliament is due to vote tomorrow on the proposal to give the pharmaceutical industry a role in providing patients with information on prescription medicines. All the signs are that it will pass most of the amendments made by MEPs to focus the proposal on the interests of patients rather than those of the industry, thereby increasing the pressure on ministers within EU nations to reach a common position themselves when they debate it on 6 December.
You may also be interested in...
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.